UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): December 22, 2004
MannKind Corporation
Delaware
|
000-50865 | 13-3607736 | ||
(State or other jurisdiction of
|
(Commission File Number) | (IRS Employer | ||
incorporation or organization)
|
Identification No.) |
| 28903 North Avenue Paine | ||
| Valencia, California | 91355 | |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s Telephone Number, Including Area Code: (661) 775-5300
N/A
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CRF 240.13e-4(c))
| Item 8.01 Other Events | ||||||||
| Item 9.01 Financial Statements and Exhibits | ||||||||
| SIGNATURE | ||||||||
| EXHIBIT INDEX | ||||||||
| Exhibit 99.1 | ||||||||
Section 8 – Other Events
Item 8.01 Other Events
On December 22, 2004, MannKind Corporation issued a press release announcing results from its US-based late phase 2 clinical study of Technosphereâ Insulin. A copy of the press release is furnished as Exhibit 99.1 to this report and is incorporated herein by reference.
Section 9 – Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits
(c) Exhibits.
| Number | Description | |
99.1
|
Press Release of MannKind Corporation dated December 22, 2004, reporting MannKind’s results from its US-based late phase 2 clinical study of Technosphere® Insulin. |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| MANNKIND CORPORATION |
||||
| By: | /s/ Richard L. Anderson | |||
| Name: | Richard L. Anderson | |||
| Title: | Chief Financial Officer | |||
| Dated: December 22, 2004 | ||||